Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-086385

Chief Executive Officer sold 2,794 shares at $4.37 ($12,210)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rawcliffe Adrian Chief Executive Officer 2021-06-28 Sale −2,794 $4.37 $12,210 3,058 D
Open-market sales · 2,794 sh · avg $4.37 · $12,210
Loading xslF345X03/tm2118429-2_4seq1.xml…